首页> 外文期刊>Journal of Nanjing Medical University >Alteration of the Cyclin D1/p16-pRB Pathway, Cellular Proliferation and Apoptosis in Glioma
【24h】

Alteration of the Cyclin D1/p16-pRB Pathway, Cellular Proliferation and Apoptosis in Glioma

机译:胶质瘤细胞周期蛋白D1 / p16-pRB途径的改变,细胞增殖和凋亡

获取原文
获取原文并翻译 | 示例
           

摘要

Objective: To study the alteration of cyclin D1, p16 and pKB in glioma, analyze proliferation and ap-optosis of tumor cells, and discuss the pathogenesis of glioma. Methods: Thirty-seven glioma specimens were classified as astrocytoma(25 cases, including 7 fibrillary cases; 6 protoplasmic cases; 12 anaplastic cases), and glioblastoma(12 cases, including 4 GBM cases). Ten normal brain tissues were taken as controls. The expression of cyclin D1, p16 and pRB were detected by immunohistochemical method. Cellular proliferation was assessed by Ki-67 label index(Ki-67 LI) .Cellular apoptosis was detected by TDNEL and apoptotic indices(AI)was calculated. Results: The alterations of three proteins were cyclin D1 overexpression(28/37,75.7%), p16 and pKB deletion(20/37,54.1 % and 12/37, 32.4%) which were closely related to tumor types, particularly in malignant glioma. Ki-67 LI and AI were higher when pRB pathway was abnormal . Apoptosis was minor in astrocytic tumors (astrocytomas, 0.010 +- 0.002; glioblastomas, 0.057 +- 0.016). Conclusion: The abnormalities of cyclin D1/p16-pRB pathway correlated closely with pathogenesis of glioma.
机译:目的:研究神经胶质瘤中cyclin D1,p16和pKB的变化,分析肿瘤细胞的增殖和凋亡,探讨神经胶质瘤的发病机制。方法:将37例神经胶质瘤标本分为星形细胞瘤(25例,其中7例为原纤维瘤; 6例原浆性; 12例间变性)和胶质母细胞瘤(12例,其中4例GBM)。将十个正常脑组织作为对照。免疫组化法检测cyclin D1,p16和pRB的表达。用Ki-67标记指数(Ki-67 LI)评估细胞增殖,用TDNEL法检测细胞凋亡,并计算凋亡指数(AI)。结果:三种蛋白的变化为细胞周期蛋白D1过表达(28 / 37,75.7%),p16和pKB缺失(20 / 37,54.1%和12/37,32.4%),这与肿瘤类型密切相关,尤其是恶性肿瘤。胶质瘤。 pRB途径异常时,Ki-67 LI和AI较高。在星形细胞肿瘤中凋亡较小(星形细胞瘤,0.010±0.002;成胶质细胞瘤,0.057±0.016)。结论:细胞周期蛋白D1 / p16-pRB通路异常与神经胶质瘤的发病机制密切相关。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号